Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis

被引:8
|
作者
Degraeuwe, PLJ
Beuman, GH
van Tiel, FH
Maertzdorf, WJ
Blanco, CE
机构
[1] Univ Hosp Maastricht, Dept Paediat, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands
[3] Univ Hosp Maastricht, Dept Clin Microbiol, NL-6202 AZ Maastricht, Netherlands
来源
BIOLOGY OF THE NEONATE | 1998年 / 73卷 / 05期
关键词
teicoplanin; pharmacology; adverse effects; Gram-positive bacterial infections; drug therapy;
D O I
10.1159/000013987
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To study the clinical pharmacology of teicoplanin in babies admitted to a newborn intensive care unit, by monitoring serum levels, efficacy and potential side effects. Methods: An open, nonrandomized descriptive study was performed in the neonatal intensive and high care unit of the University Hospital Maastricht, The Neterlands. Twenty-three preterm neonates, gestational age ranging from 26 to 32 weeks (median 28.4 weeks), postnatal age from 5 to 47 days, and birth weight from 570 to 1,740 g, presenting with (suspected) late onset septicemia, were studied. Of 21 culture-proven septicemias, 20 were caused by staphylococci. The teicoplanin loading dose was 15 mg/kg i.v., followed by a maintenance dose of 8 mg/kg every 24 h. Intravenous gentamicin was also administered pending blood culture. Serum teicoplanin concentrations were measured by fluorescence polarization immunoassay. Clinical and microbiological cure/failure rates were determined and possible side effects were monitored. Results: The study of individual pharmacokinetics during multiple-dose intravenous infusions was rendered impossible by apparently inaccurate dosing. Peak (30 min after end of the infusion) and trough teicoplanin levels were stable throughout the study and averaged 27.8 (interquartile range 23.7-32.9) and 12.3 (interquartile range 9.1-16.8) mg/l, respectively. The microbiological and clinical cure rates were 90% in gram-positive septicemia. There was no apparent toxicity. Conclusions: Inaccurate drug administration was a problem in this study, making a multidose pharmacokinetic study impossible. It is possible that inaccurate drug administration and not current dosage guidelines yielded trough levels below 10 mg/l in 57 (32%) of 176 instances. This pharmaceutical aspect clearly warrants further study. However, microbiological and clinical cure rates were high in gram-positive septicemias, No side effects attributable to teicoplanin therapy were encountered.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 50 条
  • [31] FOCUSED PROTEOMIC PROFILING FOR RAPID DETECTION OF LATE-ONSET NEONATAL SEPSIS IN PRETERM INFANTS
    Cannon, D. C.
    Ohls, R. K.
    Hartenberger, C.
    Peceny, H.
    Ballard, K.
    Mani, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (01) : 235 - 235
  • [32] Diagnostic utility of the systemic immune-inflammatory index in preterm neonates with late-onset sepsis
    Vardar, Gonca
    Ozek, Eren
    MARMARA MEDICAL JOURNAL, 2023, 36 (03): : 319 - 325
  • [33] Massage therapy reduces hospital stay and occurrence of late-onset sepsis in very preterm neonates
    Mendes, E. W.
    Procianoy, R. S.
    JOURNAL OF PERINATOLOGY, 2008, 28 (12) : 815 - 820
  • [34] CLINICAL MICROBIOLOGY OF EARLY-ONSET AND LATE-ONSET NEONATAL SEPSIS, PARTICULARLY AMONG PRETERM BABIES
    Kristof, Katalin
    Kocsis, Erika
    Nagy, K.
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2009, 56 (01) : 21 - 51
  • [35] Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis
    Yalaz, M
    Cetin, H
    Akisu, M
    Yeniay, B
    Tunger, A
    Kultursay, N
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (05) : 540 - 548
  • [36] Selenium Supplementation for Prevention of Late-Onset Sepsis in Very Low Birth Weight Preterm Neonates
    Aggarwal, Rahul
    Gathwala, Geeta
    Yadav, Sudesh
    Kumar, Pawan
    JOURNAL OF TROPICAL PEDIATRICS, 2016, 62 (03) : 185 - 193
  • [37] Massage therapy reduces hospital stay and occurrence of late-onset sepsis in very preterm neonates
    E W Mendes
    R S Procianoy
    Journal of Perinatology, 2008, 28 : 815 - 820
  • [38] Carboxyhemoglobin as biomarker of late-onset sepsis in preterm infants
    Dani, Carlo
    Remaschi, Giulia
    Monti, Nicolo
    Pratesi, Simone
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (10) : 4523 - 4528
  • [39] Late-Onset Sepsis Among Very Preterm Infants
    Flannery, Dustin D.
    Edwards, Erika M.
    Coggins, Sarah A.
    Horbar, Jeffrey D.
    Puopolo, Karen M.
    PEDIATRICS, 2022, 150 (06)
  • [40] Presepsin for the Detection of Late-Onset Sepsis in Preterm Newborns
    Poggi, Chiara
    Bianconi, Tommaso
    Gozzini, Elena
    Generoso, Marta
    Dani, Carlo
    PEDIATRICS, 2015, 135 (01) : 68 - 75